Home › Entities › clinical_trial › The Rifaximin Study in CVID

The Rifaximin Study in CVID

clinical trial
MedicalStudy clinical_trial Q64354379
Press Enter · cited answer in seconds

Summary

The Rifaximin Study in CVID is a clinical trial[1].

Key Facts

  • The Rifaximin Study in CVID is in the country of Norway[2].
  • The Rifaximin Study in CVID's instance of is recorded as clinical trial[3].
  • The Rifaximin Study in CVID's start time is recorded as +2013-10-31T00:00:00Z[4].
  • The Rifaximin Study in CVID's end time is recorded as +2014-12-31T00:00:00Z[5].
  • The Rifaximin Study in CVID's sponsor is recorded as Oslo University Hospital[6].
  • The Rifaximin Study in CVID's main subject is recorded as common variable immunodeficiency[7].
  • The Rifaximin Study in CVID's number of participants is recorded as {'unit': '1', 'amount': '+40'}[8].
  • The Rifaximin Study in CVID's title is recorded as Effects of Rifaximin, by Modulation of the Gut Microbiota, on Markers of Systemic Inflammation in Patients With Common Variable Immunodeficiency - An Exploratory Open-label Randomized Controlled Trial[9].
  • The Rifaximin Study in CVID's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[10].
  • The Rifaximin Study in CVID's ClinicalTrials.gov ID is recorded as NCT01946906[11].
  • The Rifaximin Study in CVID's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+74'}[12].
  • The Rifaximin Study in CVID's research intervention is recorded as rifaximin[13].
  • The Rifaximin Study in CVID's clinical trial phase is recorded as phase IV clinical trial[14].
  • The Rifaximin Study in CVID's research site is recorded as University of Oslo[15].
  • The Rifaximin Study in CVID's study type is recorded as interventional study[16].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). The Rifaximin Study in CVID. Retrieved May 3, 2026, from https://4ort.xyz/entity/the-rifaximin-study-in-cvid
MLA “The Rifaximin Study in CVID.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/the-rifaximin-study-in-cvid.
BibTeX @misc{4ortxyz_the-rifaximin-study-in-cvid_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{The Rifaximin Study in CVID}}, year = {2026}, url = {https://4ort.xyz/entity/the-rifaximin-study-in-cvid}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): The Rifaximin Study in CVID — https://4ort.xyz/entity/the-rifaximin-study-in-cvid (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/the-rifaximin-study-in-cvid · Last refreshed: